Complete heart block associated with regadenoson: a real side effect.
Division of Cardiovascular Diseases, Mayo Clinic in Arizona, 13400 E Shea Blvd., Scottsdale, AZ 85259, USA. pandit.anil@mayo.edu
Anil
A
Pandit
Samuel
S
Unzek Freiman
D058908:Adenosine A2 Receptor Agonists / Q000009:adverse effects; D000368:Aged; D000628:Aminophylline / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use; D005260:Female; D006327:Heart Block / Q000139:chemically induced* / Q000188:drug therapy; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D016030:Kidney Transplantation; D055414:Myocardial Perfusion Imaging / Q000379:methods; D057234:Preoperative Period; D011687:Purines / Q000008:administration & dosage / Q000009:adverse effects*; D011720:Pyrazoles / Q000008:administration & dosage / Q000009:adverse effects*; D006435:Renal Dialysis; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000009:adverse effects*
D058908:Adenosine A2 Receptor Agonists; D001993:Bronchodilator Agents; D011687:Purines; D011720:Pyrazoles; D014665:Vasodilator Agents; D000628:Aminophylline; C430916:regadenoson